Ribavirin therapy for severe COVID-19: a retrospective cohort study

The aim of this study was to compare ribavirin therapy versus supportive therapy only for patients with severe coronavirus disease 2019 (COVID-19). A total of 115 patients with laboratory-confirmed COVID-19 were retrospectively analysed. All patients received supportive care as well as regular labor...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Song, Su, Yuan, Yu, Yuan, Wu, Chuangyan, Chen, Jiuling, Wang, Sihua, Jiang, Jinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377772/
https://www.ncbi.nlm.nih.gov/pubmed/32712334
http://dx.doi.org/10.1016/j.ijantimicag.2020.106114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377772/
https://www.ncbi.nlm.nih.gov/pubmed/32712334
http://dx.doi.org/10.1016/j.ijantimicag.2020.106114

Ejemplares similares